Division of Genomic Medicine Program for Promoting Platform of Genomics based Drug Discovery

Outline

Key Fields Health and Clinical Data Project, Cancer, Life style disease (Diabetes, Hypertension etc.), Neurological and Psychiatric disorders, Aging and Dementia, Intractable disease/Rare disease, Child health and development, other, Japan Genomic Medicine Program(1st)
program year 04/01/15-
R&D phase Basic Study, Applied Study, Nonclinical Study/Pre-clinical Study, Clinical Study, None
Contact
Division of Genomic Medicine, Department of Health and Clinical Data Program for Promoting Platform of Genomics based Drug Discovery SASAMATA Masao, SHIBA Yoshiki, TAKAHASHI Shuntaro, TAKAI Takako
Address: 22F Yomiuri Shimbun Bldg. 1-7-1 Otemachi, Chiyoda-ku, Tokyo 100-0004 Japan
TEL: +81-3-6870-2228
E-mail: genomic-medicine”AT”amed.go.jp

Overview

This project promotes basic research with a view to the practical implementation of genomic medicine, such as screening for causative genes by means of disease genome analysis and their functional evaluation, as well as validation studies with a view to their clinical application, and is also encouraging the research necessary to resolve the ethical, legal, and social issues posed by the provision of genomic therapy and to establish a training system for medical professionals.

Management and Evaluation Framework

PS(Program Supervisor)
  • MIZUTANI Shuki, M.D., Ph.D., Professor Emeritus, Tokyo Medical and Dental University
PO(Program Officer)
  • NAKAGAWA Hidewaki, M.D., Ph.D., Team Leader, RIKEN Center for Integrative Medical Sciences
  • TORASHIMA Yasuhiro, M.D., Ph.D., Director of Surgery, Juzenkai Hospital

Last updated 04/26/21